Clinical Trials Directory

Trials / Terminated

TerminatedNCT00805597

Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes

A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Chinese Academy of Medical Sciences · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate postmastectomy radiotherapy in breast cancer patients with one to three positive nodes.

Detailed description

Eligible breast cancer patients with mastectomy and axillary dissection are randomized into 2 groups:radiotherapy of 50 Gy in 25 fractions within 5 weeks to ipsilateral chest wall and supraclavicular nodal region,and no radiotherapy. During and after radiotherapy, the patients are followed and the efficacy and toxicities of radiotherapy are evaluated.

Conditions

Interventions

TypeNameDescription
RADIATIONradiationradiotherapy of 50Gy/25f/5w to the chest wall and supraclavicular nodal region
RADIATIONno radiationno radiotherapy

Timeline

Start date
2008-06-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2008-12-09
Last updated
2016-08-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00805597. Inclusion in this directory is not an endorsement.